NCT03737188View on ClinicalTrials.gov

Institut Fuer Diabetes-Technologie Surveillance Program

NACompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

November 14, 2018

Primary Completion Date

December 5, 2018

Study Completion Date

December 5, 2018

Conditions
Diabetes
Interventions
DEVICE

Blood glucose monitoring systems for self-testing

Capillary blood samples will be used for the evaluation of system accuracy.

Trial Locations (1)

89081

Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft an der Universität Ulm, Ulm

All Listed Sponsors
lead

Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm

OTHER

NCT03737188 - Institut Fuer Diabetes-Technologie Surveillance Program | Biotech Hunter | Biotech Hunter